CereVu Medical, Inc.

San Francisco, CA · Medtech · Private

Wearable device that monitors biomarkers of pain, dyspnea, and coughing dynamics plus vital signs, with remote patient monitoring system for respiratory disease surveillance

Grants
$1.8M
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
4
0 granted · 4 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I: A Wearable for Remote Monitoring of the COVID-19 Patient Population$256,000
Federal grantNational Science Foundation · Phase II · SBIR Phase II:Remote Monitoring of Patients in Respiratory Distress$1,577,995
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1605Acurion, Inc.—$4.1M
1606NV MEDTECH, Inc.—$21M
1607Emblok, Inc.—$6.0M
1608CereVu Medical, Inc.——
1609TREYSTA MEDICAL TECHNOLOGIES INC—$183K
1610AROMHA, INC.—$425K
1611WR Biotech, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 4
  • System And Method For Quantitatively Measuring Dyspneaapplication
  • System And Method For Quantitatively Measuring Dyspneaapplication
  • Quantitative Measurement Of Dyspneaapplication
  • System And Method For Quantitatively Measuring Dyspneaapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.